Idiopathic Pulmonary Fibrosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

  • Single User License $3500

Idiopathic Pulmonary Fibrosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Status : March, 2020 | Pharmaceutical | PPT format

Report Digest


Global Idiopathic Pulmonary Fibrosis Treatment Market: Overview 

The global idiopathic pulmonary fibrosis (IPF) treatment market has witnessed a steadfast growth over the years, on account of the increasing lung diseases worldwide. Idiopathic pulmonary fibrosis refers to the chronic lung disease, which results in progressive reduction in all lung functions. In this condition, the damaging and thickening of the air sac’s (also known as alveoli) walls is mostly expected. Several common symptoms associated with this idiopathic pulmonary fibrosis include fatigue, nail clubbing, and dry cough, and shortness of breath. Therefore, the effective treatment is necessary in order to reduce the mortality rate due to IPF. This factor is fueling growth in the global idiopathic pulmonary fibrosis treatment market. 

In terms of drug classes, the global idiopathic pulmonary fibrosis treatment market is segmented into tyrosine kinase inhibitors, antifibrotic, and autotoxin inhibitors. Presence of strong drug pipeline positively influences the growth of the segment. The report examines the recent trends in the global idiopathic pulmonary fibrosis treatment market related to the supply, demand, and sales. Moreover, it represents major growth drivers, recent developments, opportunities, and restraints in the market. 

Global Idiopathic Pulmonary Fibrosis Treatment Market: Notable Developments 

Some of the recent developments which help in altering the global idiopathic pulmonary fibrosis treatment market’s dynamics in a positive way include: 

  • FDA has permitted to design the orphan-drug, MN-001 for the treatment of idiopathic pulmonary fibrosis. 
  • MediciNova, the company presents data on MN-001, which is known as tipelukast for the treatment of IPF. 

Some of the most prominent competitors operating in the competitive landscape of global idiopathic pulmonary fibrosis treatment market include –

  • Merck &Co.
  • Cipla
  • Biogen
  • Promedior
  • Biogen

Global Idiopathic Pulmonary Fibrosis Treatment Market: Key Growth Drivers 

A few drivers which positively impact the growth of the global idiopathic pulmonary fibrosis treatment include: 

Rapid Increase in Cigarette Smoking Population Fillips Market 

Idiopathic pulmonary fibrosis is known as an interstitial lung disease, in which the lung tissues are majorly get affected or sometimes damaged. Therefore, IPF reduces the lung’s oxygen delivering capacity. Rising prevalence of several fibrotic diseases pose a high risk factor to develop idiopathic pulmonary fibrosis. Along with this, burgeoning population’s inclination towards smoking cigarettes and commercialization of novel drugs are some of the crucial factors stimulating the growth of the global idiopathic pulmonary fibrosis treatment market. 

The major symptoms noticed in the idiopathic pulmonary fibrosis are muscle and joint pain and rapid weight loss. However, further complications include heart failure, hypertension, and pneumonia or pulmonary embolism. Hence, global need to prevent these conditions is also responsible for propelling expansion in the global idiopathic pulmonary fibrosis treatment market. 

Geriatric Population Suffering from IPF to Foster Market’s Growth 

Several other factors responsible for the severe damage of lung tissues include the attack of certain viruses such as herpes virus and Epstein Barr virus, acid reflux from stomach, and numerous environmental factors such as breathing in the presence of dust such as asbestos fibers, silica dust, coal dust, and metal dust. To avoid such severity of lung diseases, treatments are available for the condition of idiopathic pulmonary fibrosis, which include oxygen therapy, symptom management, pulmonary rehabilitation, and lung transplant. 

Moreover, various prescribed antifibrotic drugs such as Nintedanib and Pirfenidone are widely used in order to treat the condition of IPF. All these factors are providing major impetus to the growth of the global idiopathic pulmonary fibrosis treatment market. Additionally, the global idiopathic pulmonary fibrosis treatment market is growing consistently on account of the burgeoning population suffering from idiopathic pulmonary fibrosis. 

Global Idiopathic Pulmonary Fibrosis Treatment Market: Regional Outlook 

Geographically, North America is dominating the global idiopathic pulmonary fibrosis treatment market as the region has witnessed a sharp increase in the population affected by idiopathic pulmonary fibrosis. Along with this, rising approval of new drugs in order to treat IPF is also responsible for fueling growth in the idiopathic pulmonary fibrosis treatment market in this region. 

The global idiopathic pulmonary fibrosis (IPF) treatment market is segmented: 

Drug Types 

  • Pirfenidone
  • Nintedanib 

Region 

  • North America
    • U.S.
    • Canada
    • Mexico 
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe 
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Rest of Asia-Pacific 
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA 

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.

Wish to check Table of Contents of this report?

Click below to Request TOC

Request TOC